Owkin

Owkin is an AI biotechnology company that has made strategic startup investments, including seed-stage backing in France. Its investor relevance is strongest for founders building in AI, biotechnology, life sciences, oncology, pharmaceuticals, diagnostics and drug discovery where alignment with multimodal patient data, clinical research or biopharma R&D matters. Based in Paris, Owkin is better suited as a strategic investor or partner than a traditional venture fund.